Candriam SCA’s Acceleron Pharma Inc. XLRN Stock Holding History

Candriam SCA’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-462,239	Closed	-$79.5M	–	908
2021 Q3	$79.5M	Sell	462,239 -94,816	-17%	-$16.3M	0.54%	43
2021 Q2	$69.9M	Buy	557,055 +121	+0%	+$15.2K	0.48%	46
2021 Q1	$68.4M	Sell	556,934 -1	-0%	-$123	0.57%	35
2020 Q4	$71.3M	Buy	556,935 +51,555	+10%	+$6.6M	0.56%	35
2020 Q3	$56.9M	Buy	505,380 +124,371	+33%	+$14M	0.53%	36
2020 Q2	$36.3M	Sell	381,009 -101,549	-21%	-$9.67M	0.38%	59
2020 Q1	$25M	Buy	482,558 +28	+0%	+$1.45K	0.28%	76
2019 Q4	$25.6M	Sell	482,530 -68,970	-13%	-$3.66M	0.27%	76
2019 Q3	$21.8M	Buy	551,500 +169,552	+44%	+$6.7M	0.29%	69
2019 Q2	$15.6M	Buy	381,948 +141,448	+59%	+$5.79M	0.19%	120
2019 Q1	$11.2M	Sell	240,500 -2,258	-0.9%	-$105K	0.14%	167
2018 Q4	$10.6M	Buy	242,758 +117,758	+94%	+$5.13M	0.16%	147
2018 Q3	$7.15M	Buy	125,000 +28,000	+29%	+$1.6M	0.1%	249
2018 Q2	$4.71M	Buy	97,000 +37,000	+62%	+$1.8M	0.07%	305
2018 Q1	$2.35M	Sell	60,000 -13,000	-18%	-$508K	0.04%	446
2017 Q4	$3.1M	Sell	73,000 -45,000	-38%	-$1.91M	0.05%	370
2017 Q3	$4.4M	Buy	118,000 +10,000	+9%	+$373K	0.08%	289
2017 Q2	$3.28M	Sell	108,000 -74,000	-41%	-$2.25M	0.06%	354
2017 Q1	$4.82M	Buy	182,000 +31,000	+21%	+$821K	0.09%	260
2016 Q4	$3.85M	Buy	151,000 +57,000	+61%	+$1.45M	0.09%	252
2016 Q3	$3.4M	Buy	94,000 +14,000	+18%	+$507K	0.08%	259
2016 Q2	$2.72M	Sell	80,000 -35,000	-30%	-$1.19M	0.07%	266
2016 Q1	$3.02M	Sell	115,000 -5,000	-4%	-$131K	0.08%	264
2015 Q4	$5.85M	Buy	120,000 +19,200	+19%	+$936K	0.16%	152
2015 Q3	$2.51M	Buy	100,800 +800	+0.8%	+$19.9K	0.06%	307
2015 Q2	$3.16M	Buy	100,000 +32,000	+47%	+$1.01M	0.07%	304
2015 Q1	$2.59M	Buy	68,000 +13,000	+24%	+$495K	0.05%	356
2014 Q4	$2.14M	Buy	+55,000	New	+$2.14M	0.04%	350